Carbamazepine
- Product NDC
- 71930-073
- 11-digit product format
- 719300073
- Labeler code
- 71930
- Product ID
- 71930-073_fe788fd8-8083-4201-af83-010af795d108
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Carbamazepine
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Eywa Pharma Inc
- Application
- ANDA212948
- Marketing category
- ANDA
- Marketing start
- 2021-10-15
- Marketing end
- 0000-00-00
- Substance
- CARBAMAZEPINE
- Active strength
- 200 mg/1
- Pharmacologic classes
- Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC],Cytochrome P450 3A4 Inducers [MoA],Cytochrome P450 1A2 Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 2C19 Inducers [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 71930-073 | CARBAMAZEPINE ER (CARBAMAZEPINE) TABLET, EXTENDED RELEASE [EYWA PHARMA INC] | 1 | Legacy NDC | 20211016_48010b2b-526b-4bd6-87fd-87745c22cb8f.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71930-073-12 | 71930007312 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (71930-073-12) | 2021-10-15 | 0000-00-00 | No | No | Current |